Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
3.040
+0.320 (11.76%)
At close: Mar 9, 2026, 4:00 PM EDT
3.050
+0.010 (0.33%)
After-hours: Mar 9, 2026, 5:41 PM EDT
Esperion Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 716 | 433 | 340 | 459 | 306 | 725 | |
| Market Cap Growth | 96.35% | 27.49% | -25.93% | 49.97% | -57.77% | -55.52% | |
| Enterprise Value | 1,224 | 848 | 757 | 815 | 726 | 687 | |
| Last Close Price | 3.04 | 2.20 | 2.99 | 6.23 | 5.00 | 26.00 | |
| Forward PE | 7.72 | 16.60 | - | - | - | - | |
| PS Ratio | 2.36 | 1.30 | 2.92 | 6.08 | 3.90 | 3.19 | |
| PB Ratio | - | -1.11 | -0.75 | -1.42 | -1.55 | -7.54 | |
| EV/Sales Ratio | 4.03 | 2.55 | 6.51 | 10.79 | 9.26 | 3.02 | |
| EV/EBITDA Ratio | - | 15.58 | - | - | - | - | |
| EV/EBIT Ratio | - | 15.59 | - | - | - | - | |
| Debt / Equity Ratio | -1.33 | -1.52 | -1.19 | -1.56 | -2.63 | -3.77 | |
| Debt / EBITDA Ratio | - | 10.29 | - | - | - | - | |
| Net Debt / Equity Ratio | -1.13 | -1.15 | -1.01 | -1.04 | -1.31 | -0.59 | |
| Net Debt / EBITDA Ratio | -17.37 | 8.20 | -2.95 | -1.89 | -1.21 | -0.47 | |
| Net Debt / FCF Ratio | -5.45 | -18.62 | -3.39 | -1.93 | -0.98 | -0.66 | |
| Asset Turnover | 0.90 | 1.21 | 0.51 | 0.24 | 0.21 | 0.80 | |
| Inventory Turnover | 1.55 | 1.43 | 2.57 | 4.19 | 4.76 | - | |
| Quick Ratio | 0.59 | 0.91 | 0.84 | 2.17 | 3.85 | 3.37 | |
| Current Ratio | 1.00 | 1.37 | 1.29 | 2.67 | 4.49 | 3.68 | |
| Return on Assets (ROA) | -5.42% | 12.37% | -42.86% | -35.64% | -36.31% | -26.73% | |
| Return on Capital Employed (ROCE) | -589.10% | 55.70% | -313.80% | -115.30% | -69.30% | -46.80% | |
| Earnings Yield | -14.79% | -11.94% | -61.54% | -50.90% | -87.91% | -19.81% | |
| FCF Yield | -13.03% | -5.53% | -39.85% | -38.09% | -86.18% | -11.87% | |
| Buyback Yield / Dilution | -18.70% | -81.54% | -55.26% | -129.76% | -5.20% | -1.42% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.